These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23688200)

  • 41. A prospective intra-individual evaluation of silk compared to Biobrane for the treatment of superficial burns of the hand and face.
    Schiefer JL; Arens E; Grigutsch D; Rath R; Hoffmann A; Fuchs PC; Schulz A
    Burns; 2017 May; 43(3):539-548. PubMed ID: 28043735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-1908 promotes scar formation post-burn wound healing by suppressing Ski-mediated inflammation and fibroblast proliferation.
    Xie C; Shi K; Zhang X; Zhao J; Yu J
    Cell Tissue Res; 2016 Nov; 366(2):371-380. PubMed ID: 27256397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal Timing for Early Excision in a Deep Partial Thickness Porcine Burn Model.
    Toussaint J; Chung WT; Mc Clain S; Raut V; Singer AJ
    J Burn Care Res; 2017; 38(1):e352-e358. PubMed ID: 27437953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence-Based Scar Management: How to Improve Results with Technique and Technology.
    Khansa I; Harrison B; Janis JE
    Plast Reconstr Surg; 2016 Sep; 138(3 Suppl):165S-178S. PubMed ID: 27556757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Challenging the dogma: relationship between time to healing and formation of hypertrophic scars after burn injuries.
    Hassan S; Reynolds G; Clarkson J; Brooks P
    J Burn Care Res; 2014; 35(2):e118-24. PubMed ID: 23877141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin.
    Garcia-Filipe S; Barbier-Chassefiere V; Alexakis C; Huet E; Ledoux D; Kerros ME; Petit E; Barritault D; Caruelle JP; Kern P
    J Biomed Mater Res A; 2007 Jan; 80(1):75-84. PubMed ID: 16958049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment.
    Berman B; Maderal A; Raphael B
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S3-S18. PubMed ID: 27347634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of imiquimod on partial-thickness burns.
    de Mesquita CJ; Leite JA; Fechine FV; de C Rocha JL; Leite JG; Leite Filho JA; Barbosa Filho RC
    Burns; 2010 Feb; 36(1):97-108. PubMed ID: 19577848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of basic fibroblast growth factor for pediatric hand burns.
    Hayashida K; Fujioka M; Morooka S; Saijo H; Akita S
    J Tissue Viability; 2016 Nov; 25(4):220-224. PubMed ID: 27381251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor.
    Akita S; Akino K; Imaizumi T; Tanaka K; Anraku K; Yano H; Hirano A
    J Burn Care Res; 2006; 27(3):333-8. PubMed ID: 16679903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reconsideration of burn scar treatment].
    Huan JN
    Zhonghua Shao Shang Za Zhi; 2018 Oct; 34(10):672-676. PubMed ID: 30369133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pressure therapy in treatment of hypertrophic scar, burn contracture and keloid: the Kenyan experience.
    Haq MA; Haq A
    East Afr Med J; 1990 Nov; 67(11):785-93. PubMed ID: 2076679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Betamethasone in the treatment of hypertrophic scars].
    Soyka P; Zellweger GA
    Helv Chir Acta; 1980 Jun; 47(1-2):137-40. PubMed ID: 7440190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Control of hypertrophic scar from inception by using xenogenic (porcine) acellular dermal matrix (ADM) to cover deep second degree burn.
    Feng X; Tan J; Pan Y; Wu Q; Ruan S; Shen R; Chen X; Du Y
    Burns; 2006 May; 32(3):293-8. PubMed ID: 16487662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topical Oxandrolone Reduces Ear Hypertrophic Scar Formation in Rabbits.
    Sobec RL; Fodor L; Bodog F
    Plast Reconstr Surg; 2019 Feb; 143(2):481-487. PubMed ID: 30688891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth hormone effects on hypertrophic scar formation: a randomized controlled trial of 62 burned children.
    de Oliveira GV; Sanford AP; Murphy KD; de Oliveira HM; Wilkins JP; Wu X; Hawkins HK; Kitten G; Chinkes DL; Barrow RE; Herndon DN
    Wound Repair Regen; 2004; 12(4):404-11. PubMed ID: 15260805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new experimental hypertrophic scar model in guinea pigs.
    Aksoy MH; Vargel I; Canter IH; Erk Y; Sargon M; Pinar A; Tezel GG
    Aesthetic Plast Surg; 2002; 26(5):388-96. PubMed ID: 12432481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids.
    Hsu KC; Luan CW; Tsai YW
    Wounds; 2017 May; 29(5):154-158. PubMed ID: 28570253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.